Plasma Fractionation: A Leading Driver Behind Elevated Demand For Plasma Fractionation Driven By The Escalating Burden Of Chronic Diseases Market Expansion in 2025

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Will the Plasma Fractionation Industry Market Size Be by 2025?
In recent years, there has been solid growth in the size of the plasma fractionation market. The market's size will see an upward shift from $31.42 billion in 2024 to $34.44 billion in 2025, representing a compound annual growth rate (CAGR) of 9.6%. This previous period's growth has been stimulated by factors such as an increase in instances of hemophilia and immunodeficiency disorders, a rising aging population, growing demand for immunoglobulins, expansion of facilities for plasma collection, and an increased number of surgical procedures.

What's the Long-Term Growth Forecast for the Plasma Fractionation Market Size Through 2029?
The market for plasma fractionation is anticipated to experience significant surge in the forthcoming years. The worth of the market is projected to be $51.56 billion in 2029, expanding at an annual compound growth rate of 10.6%. This projected growth during the forecast period can be ascribed to increasing global health-care spending, broader usage of plasma-based medical products, heightened investment in R&D, the uptake of plasma in neurology treatments and the enlargement of plasma fractionation facilities. Within the forecast period, the market trends to note include the development of novel fractionation technologies, shift towards albumin and immunoglobulin therapies, an upswing in demand for speciality plasma products, concentration on pathogen inactivation technologies and strategic alliances and tie-ups in the plasma sector.

View the full report here:
https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

What Are the Key Growth Drivers Fueling the Plasma Fractionation Market Expansion?
The prevalence of chronic diseases, defined as health conditions lasting a year or longer that necessitate continuous medical supervision, like cancer, heart disease, and diabetes, is anticipated to fuel the progress of the plasma fractionation marketplace. The use of plasma products to treat patients with chronic diseases enhances their quality of life, reduces morbidity and is cost-effective, leading to a rise in plasma fractionation demand. A report from the US-based National Library of Medicine, dated January 2023, forecasted that the populations aged 50 and above suffering from one or more chronic diseases will increase by 99.5%, totaling 142.66 million people by 2050, a considerable jump from 71.522 million in 2020 in the United States. Hence, this escalation of chronic diseases cases is propelling the growth of the healthcare analytical testing service market. Consequently, this growth in chronic diseases across all ages is projected to drive the surge in the plasma fractionation market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

What Are the Key Trends Driving Plasma Fractionation Market Growth?
Key players in the market are adopting innovative technologies, such as state-of-the-art facility procedures that transform donated human plasma into essential drugs. These advancements make the process more effective and secure. Case in point, in March 2023, CSL Behring, a company based in Germany, inaugurated a new plasma fractionation facility worth $470 million. This facility utilizes modern technology to enhance plasma processing's efficiency and safety, ensuring higher quality and more dependable medicines. The establishment contributes to meeting the rising demand by increasing the supply of these crucial medicines, assuring that more patients have access to treatments that can save lives. The sophisticated automation and self-cleaning systems in the facility decrease the chances of contamination, improving hygiene, and further bolstering patient safety.

How Is the Plasma Fractionation Market Segmented?
The plasma fractionation market covered in this report is segmented -

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors
2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology
3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:
1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)
3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)
4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

Which Companies Are Leading the Charge in Plasma Fractionation Market Innovation?
Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Which Regions Are Leading the Global Plasma Fractionation Market in Revenue?
North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7543

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.